Persevere Trial-Triple Negative Breast Cancer

Persevere Trial-Triple Negative Breast Cancer A Phase II circulating tumor DNA enriched, genomically directed post-neoadjuvant trial for patients Please email or message the team directly with questions.

This is a Public page created for awareness of the PERSEVERE Clinical Trial. Respecting patient privacy and confidentiality is important to the study team, for doctor-patient relationships, and public trust in medical professionals. Please feel free to like, follow, and share this content at your own discretion.

Have you recently been diagnosed with triple negative breast cancer? You may be eligible for a clinical study. The goal ...
06/02/2022

Have you recently been diagnosed with triple negative breast cancer? You may be eligible for a clinical study. The goal of this study is to investigate personalized treatment combinations compared with standard cancer treatments.

is now enrolling participants in PERSEVERE. Patients with residual triple negative breast cancer, cancer tissue remai...
06/01/2022

is now enrolling participants in PERSEVERE. Patients with residual triple negative breast cancer, cancer tissue remaining despite having had chemotherapy before surgery, are invited to participate. There are additional specific criteria that your study team will review to confirm that you are eligible for this study.

TNBC treatments are improving! Immunotherapy is now considered a standard treatment, so it is now part of all arms of PE...
05/06/2022

TNBC treatments are improving! Immunotherapy is now considered a standard treatment, so it is now part of all arms of PERSEVERE!

We are excited to announce that the PERSEVERE trial (BRE18-334) is now open at Novant Health. Women with residual triple...
05/04/2022

We are excited to announce that the PERSEVERE trial (BRE18-334) is now open at Novant Health. Women with residual triple-negative breast cancer in North Carolina may be eligible to join!

The goal of genomic therapy is to kill tumor cells in a more direct way so that healthy cells are not as impacted. To le...
03/31/2022

The goal of genomic therapy is to kill tumor cells in a more direct way so that healthy cells are not as impacted.

To learn more about how genomic therapy will be used in PERSEVERE, click https://cancer.iu.edu/breast/persevere.php.

We want all patients diagnosed with triple negative breast cancer to be survivors. Help us determine the best treatment ...
03/24/2022

We want all patients diagnosed with triple negative breast cancer to be survivors. Help us determine the best treatment for triple negative breast cancer. Learn more: https://cancer.iu.edu/breast/persevere.php

You may already know that the BRCA1 and BRCA2 genes are related to breast cancer. Today we will be discussing how these ...
03/16/2022

You may already know that the BRCA1 and BRCA2 genes are related to breast cancer. Today we will be discussing how these genes are involved.

Phase 4 occurs after the drug or product is released to the public. Even though people are using the product, it is moni...
03/10/2022

Phase 4 occurs after the drug or product is released to the public. Even though people are using the product, it is monitored to ensure that it continues to be safe. This is the last post in the clinical trials series about the phases of the trials! We hope you have a better understanding clinical trials from these posts.

All of the information discussed here came from The Collaborative Institutional Training Initiative (CITI Program).

The different phases that make up clinical trials are often not known to many people. This series of posts aims to sprea...
03/03/2022

The different phases that make up clinical trials are often not known to many people. This series of posts aims to spread more information and awareness about clinical trials. To learn about the phases preceding phase 3, scroll down our page!

All of the information discussed here came from The Collaborative Institutional Training Initiative (CITI Program).

The goal of this series is to help others learn more about the phases of clinical trials. Each phase has a specific purp...
02/24/2022

The goal of this series is to help others learn more about the phases of clinical trials. Each phase has a specific purpose and ultimately, is used to ensure that people who use a specific product or drug are not posed at unreasonable risk of harm.

All of the information discussed here came from The Collaborative Institutional Training Initiative (CITI Program).

While many have heard of clinical trials, the different phases that make up a clinical trial are often unknown. Today, P...
02/17/2022

While many have heard of clinical trials, the different phases that make up a clinical trial are often unknown. Today, Phase 1 of clinical trials will be discussed to spread more awareness about what clinical trials involve.

All of the information discussed here came from The Collaborative Institutional Training Initiative (CITI Program).

Did you know that clinical trials often take 6-7 years to complete? While there are only 4 phases of clinical trials (no...
02/10/2022

Did you know that clinical trials often take 6-7 years to complete?

While there are only 4 phases of clinical trials (not counting the preclinical phase), there are many important steps that need to be taken before proceeding to a new phase. All of these phases will be discussed in the following weeks!

Address

Indianapolis, IN
46202

Website

Alerts

Be the first to know and let us send you an email when Persevere Trial-Triple Negative Breast Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Persevere Trial-Triple Negative Breast Cancer:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category